Cationic liposomes and nucleic acids

Current Opinion in Colloid and Interface Science

Volumn 6, Issue 1, 2001, Pages 78-84

  Woodle, Martin C ^a   Scaria, Puthupparampil ^a  

^a Intradigm Corporation   (United States)

Author keywords

Cationic lipid; Colloid; DNA delivery; Gene therapy; Lipoplex; Liposome; Oligonucleotide

Indexed keywords

LIPOSOME; NUCLEIC ACID;

BIOMEDICAL ENGINEERING; CANCER; CATION TRANSPORT; CELL INTERACTION; CYSTIC FIBROSIS; DNA DRUG COMPLEX; DNA VECTOR; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; MEMBRANE TRANSPORT; PERMEABILITY BARRIER; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0035084220     PISSN: 13590294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-0294(00)00091-1     Document Type: Review

References (65)

1. New directions in liposome gene delivery
2. Gene delivery mediated by cationic liposomes: From biophysical aspects to enhancement of transfection
3. Development of a novel fusogenic viral liposome system (HVJ-liposomes) and its applications to the treatment of acquired diseases
4. Lipid-based systems for the intracellular delivery of genetic drugs
5. Interaction of oligonucleotides with cationic lipids: The relationship between electrostatics, hydration and state of aggregation
6. Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency
7. Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency
8. Cationic lipid structure and formulation considerations for optimal gene transfection of the lung
9. Synthesis and characterization of aromatic ring-based cationic lipids for gene delivery in vitro and in vivo
10. Characterization of vascular gene transfer using a novel cationic lipid
11. Gene transfer mediated by YKS-220 cationic particles: Convenient and efficient gene delivery reagent
12. Characterization of a pH-sensitive surfactant, dodecyl-2(1′-imidazolyl) propionate (DIP), and preliminary studies in liposome-mediated gene transfer
13. Gene transfer by guanidinium-cholesterol: Dioleoylphosphatidyl-ethanolamine liposome-DNA complexes in aerosol
14. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery
15. Structural basis of DOTMA for its high intravenous transfection activity in mouse
16. Biological pathways to drug targeting
17. Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles
18. Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic lipid-reconstituted influenza-virus envelopes (cationic virosomes)
19. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
20. Enhancement of transfection efficiency by protamine in DDAB lipid vesicle-mediated gene transfer
21. Enhanced folate receptor-mediated gene therapy using a novel pH-sensitive lipid formulation
22. Stabilized plasmid-lipid particles for regional gene therapy: Formulation and transfection properties
23. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity
24. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides
25. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles
26. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDRI
27. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides
28. Targeted gene delivery into alpha9beta1-integrin-displaying cells by a synthetic peptide
29. Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithilial cells
30. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
31. An integrin-targeted non-viral vector for pulmonary gene therapy
32. Efficient gene transfer by transferrin lipoplexes in the presence of serum
33. In vivo gene delivery to the liver using novel galactosylated cationic liposomes
34. Sterically stabilized polyplex: Ligand-mediated activity
35. How to design an antisense oligoneoxynucleotide experiment: A consensus approach
36. Nuclear targeting of plasmid DNA in human corneal cells
37. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways
38. Transgene expression, but not gene delivery, is improved by adhesion-assisted lipofection of hematopoietic cells
39. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer
40. Structure and structure-function studies of lipid/plasmid DNA complexes
41. Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency
42. Effect of DNA/liposome mixing ratio on the physiochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression
43. Stable and monodisperse lipoplex formulations for gene delivery
44. 2+ ions
45. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA
46. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
47. Size-dependent DNA mobility in cytoplasm and nucleus
48. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial
49. Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: Comparison with protein therapy
50. Combination surgery and non-viral interleukin 2 gene therapy for head and neck cancer
51. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases
52. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse
53. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model
54. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models
55. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience
56. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously
57. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
58. Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes
59. Antiangiogenic gene therapy in cancer
60. Systemic gene delivery expands the repertoire of effective antiangiogenic agents
61. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo
62. Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells: A word of caution
63. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid:cationic lipid complexes
64. Toxicity of cationic liposome-DNA complex in lung isografts
65. Mechanisms of protection of cationic lipid-DNA complexes during lyophilization